Theories behind rare blood clots related to COVID-19 vaccines – Karolina Bentkowska

AstraZeneca and Johnson & Johnson are two amongst many vaccines which have been accepted for immunisation against SARS-CoV-2 (coronavirus) – the virus causing the COVID-19 pandemic. Despite passing all clinical trials and being approved for emergency use to halt the spread of coronavirus, these vaccines have recently made headlines due to their possible link to rare cases of blood clots, some of which were fatal. When the correlation was first suspected for the Read more about Theories behind rare blood clots related to COVID-19 vaccines – Karolina Bentkowska[…]

Theories behind rare blood clots related to COVID-19 vaccines – Karolina Bentkowska

AstraZeneca and Johnson & Johnson are two amongst many vaccines which have been accepted for immunisation against SARS-CoV-2 (coronavirus) – the virus causing the COVID-19 pandemic. Despite passing all clinical trials and being approved for emergency use to halt the spread of coronavirus, these vaccines have recently made headlines due to their possible link to Read more about Theories behind rare blood clots related to COVID-19 vaccines – Karolina Bentkowska[…]

An Interview with Hannah Semple: Research Scientist at AstraZeneca – Rebecca Chatwin

On the 28th of January this academic year 2018/2019, the Biomedical and Life Sciences department was delighted to welcome some Lancaster Alumni to talk to our students about their current profession and past experiences. These alumni were Hannah Semple (Research Scientist), Kate Anderton (Scientific Editor) and Hannah Fagg (Trainee Healthcare scientist in Genomic Counselling). I Read more about An Interview with Hannah Semple: Research Scientist at AstraZeneca – Rebecca Chatwin[…]